Zhaoyan Pharmaceutical (06127) announced interim results. Profit attributable to shareholders of about 748 million yuan increased by about 11.27 times year-on-year

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Zhaoyan New Pharmaceutical (06127) announced its 2026 interim results, with revenue of about 704 million yuan, an increase of 5.3% over the previous year; the profit due to the company's equity shareholders was about 748 million yuan, an increase of about 11.27 times the previous year; profit per share.

During the reporting period, the company's overall order amount was about 3.7 billion yuan, an increase of 60.9% over the previous year; the amount of new orders signed was about 2.02 billion yuan, an increase of 98.0% over the previous year.

According to the announcement, the increase in net profit was mainly due to changes in the fair value of biological assets.